171. J Inorg Biochem. 2018 Jun;183:77-83. doi: 10.1016/j.jinorgbio.2018.03.010. Epub2018 Mar 16.Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicityand evaluation against drug-resistant tuberculosis.de Oliveira LP(1), Carneiro ZA(2), Ribeiro CM(3), Lima MF(1), Paixão DA(1),Pivatto M(1), de Souza MVN(4), Teixeira LR(5), Lopes CD(2), de Albuquerque S(2), Pavan FR(3), Guerra W(6).Author information: (1)Instituto de Química, Universidade Federal de Uberlândia, Campus Santa Mônica,Uberlândia, MG, Brazil.(2)Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdadede Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.(3)Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista,Laboratório de Pesquisa em Tuberculose, Campus Araraquara, Araraquara, SP,Brazil.(4)Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-FarManguinhos,Manguinhos, Rio de Janeiro, RJ, Brazil.(5)Departamento de Química, Universidade Federal de Minas Gerais, Belo Horizonte,MG, Brazil.(6)Instituto de Química, Universidade Federal de Uberlândia, Campus Santa Mônica,Uberlândia, MG, Brazil. Electronic address: wendell.guerra@ufu.br.This work describes the synthesis, characterization and biological evaluation of three platinum complexes of the type [Pt(DMSO)(L)Cl]Cl, in which L represents afluoroquinolone, namely, ciprofloxacin (cpl), ofloxacin (ofl), or sparfloxacin(spf). The new complexes were characterized by elemental analysis,high-resolution mass spectrometry (HRESIMS) and 1H, 13C and 195Pt NMR (nuclearmagnetic resonance). The spectral data suggest that the fluoroquinolones act asbidentate ligands coordinated to Pt(II) through the nitrogen atoms of thepiperazine ring. Microbiological assays against wild type Mycobacteriumtuberculosis (ATCC 27294) showed that all complexes have been very potent,exhibiting antitubercular potency at concentrations <2 μM, although none of thecomplexes presented higher potency than established anti-TB drugs. As to theresistant strains, the complex with sparfloxacin, [Pt(DMSO)(spf)Cl]Cl exhibitedthe best potential against most Mycobacterium tuberculosis clinical isolates. Thecytotoxicity of these compounds was also evaluated in three breast cell lines:MCF-10 (a healthy cell), MCF-7 (a hormone responsive cancer cell) and MDA-MB-231 (triple negative breast cancer cell). In both tumor cell lines,[Pt(DMSO)(spf)Cl]Cl was more active and more selective than cisplatin. Flowcytometry analysis revealed that [Pt(DMSO)(spf)Cl]Cl induced late apoptotic cell death in MDA-MB-231 cells.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.jinorgbio.2018.03.010 PMID: 29567518 